Norwalk Leslie V, a director, made two open market sales of Neurocrine Biosciences Inc. ($NBIX) shares totaling about $946,000, with the most recent on December 16, 2025. These rank 5,061st among over 11,678 individual insiders. The director also sold Globus Medical Inc. ($GMED) shares twice for $558,000 total, most recently on January 8, 2026, ranking 6,208th. This activity falls below the average insider sale of 8.6 million across 6.37 transactions. Norwalk Leslie V recorded no open market purchases in the last year.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | GLOBUS MEDICAL INC | $GMED | Norwalk Leslie V | Not found | A | Stock Option (Right to Buy Class A Common Stock) | 15000 | $0.00 | 15,000.0000 | 137,219,000 | 9999.99% | 0.01% |
| Jan. 8, 2026 | GLOBUS MEDICAL INC | $GMED | Norwalk Leslie V | Not found | S | Class A Common Stock | 2000 | $101.10 | 10,419.0000 | 137,219,000 | 16.10% | 0.00% |
| Dec. 15, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Non-Qualified Stock Option | 8276 | $0.00 | 557.0000 | 102,500,000 | 93.69% | 0.01% |
| Dec. 16, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | S | Common Stock | 1190 | $155.09 | 6,239.0000 | 102,500,000 | 16.02% | 0.00% |
| Dec. 15, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | S | Common Stock | 5000 | $152.23 | 7,429.0000 | 102,500,000 | 40.23% | 0.00% |
| Dec. 15, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Common Stock | 8276 | $92.35 | 10,705.0000 | 102,500,000 | 340.72% | 0.01% |
| Dec. 15, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Common Stock | 1724 | $84.95 | 12,429.0000 | 102,500,000 | 16.10% | 0.00% |
| Dec. 15, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Non-Qualified Stock Option | 1724 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Dec. 12, 2025 | GLOBUS MEDICAL INC | $GMED | Norwalk Leslie V | Not found | S | Class A Common Stock | 4000 | $88.85 | 12,419.0000 | 137,219,000 | 24.36% | 0.00% |
| Nov. 20, 2025 | CVS HEALTH Corp | $CVS | Norwalk Leslie V | Director | A | Common Stock | 1652 | $76.04 | 5,929.0000 | 1,269,000,000 | 38.63% | 0.00% |
| June 25, 2025 | ARVINAS, INC. | $ARVN | Norwalk Leslie V | Director | A | Common Stock | 16025 | $0.00 | 26,045.0000 | 68,800,000 | 159.93% | 0.02% |
| June 25, 2025 | ARVINAS, INC. | $ARVN | Norwalk Leslie V | Director | A | Stock Option (right to buy) | 23105 | $0.00 | 23,105.0000 | 68,800,000 | 9999.99% | 0.03% |
| May 21, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | A | Restricted Stock Unit | 1659 | $0.00 | 1,659.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 21, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | A | Non-Qualified Stock Option | 3305 | $0.00 | 3,305.0000 | 103,700,000 | 9999.99% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Restricted Stock Unit | 1435 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Common Stock | 1435 | $0.00 | 2,429.0000 | 103,700,000 | 144.37% | 0.00% |
| May 15, 2025 | CVS HEALTH Corp | $CVS | Norwalk Leslie V | Director | A | Common Stock | 2077 | $60.47 | 4,277.0000 | 1,262,000,000 | 94.41% | 0.00% |
| Jan. 23, 2025 | GLOBUS MEDICAL INC | $GMED | Norwalk Leslie V | Not found | A | Stock Option (Right to Buy Class A Common Stock) | 15000 | $0.00 | 15,000.0000 | 137,863,000 | 9999.99% | 0.01% |
| Nov. 21, 2024 | CVS HEALTH Corp | $CVS | Norwalk Leslie V | Director | A | Common Stock | 2200 | $57.10 | 2,200.0000 | 1,262,000,000 | 9999.99% | 0.00% |
| July 11, 2024 | GLOBUS MEDICAL INC | $GMED | Norwalk Leslie V | Not found | S | Class A Common Stock | 1000 | $70.00 | 16,419.0000 | 114,630,000 | 5.74% | 0.00% |
| May 29, 2024 | ARVINAS, INC. | $ARVN | Norwalk Leslie V | Director | A | Common Stock | 5899 | $0.00 | 10,020.0000 | 68,000,000 | 143.14% | 0.01% |
| May 29, 2024 | ARVINAS, INC. | $ARVN | Norwalk Leslie V | Director | A | Stock Option (right to buy) | 9070 | $0.00 | 9,070.0000 | 68,000,000 | 9999.99% | 0.01% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | A | Restricted Stock Unit | 1435 | $0.00 | 1,435.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | A | Non-Qualified Stock Option | 2982 | $0.00 | 2,982.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Common Stock | 2100 | $0.00 | 2,100.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | S | Common Stock | 1106 | $141.82 | 994.0000 | 101,000,000 | 52.67% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Restricted Stock Unit | 2100 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| March 15, 2024 | GLOBUS MEDICAL INC | $GMED | Norwalk Leslie V | Not found | S | Class A Common Stock | 10590 | $51.99 | 17,419.0000 | 114,630,000 | 37.81% | 0.01% |
| Feb. 27, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Common Stock | 8000 | $84.95 | 8,000.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 27, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | S | Common Stock | 8000 | $135.67 | 0.0000 | 101,000,000 | 100.00% | 0.01% |
| Feb. 27, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | M | Non-Qualified Stock Option | 8000 | $84.95 | 1,724.0000 | 101,000,000 | 82.27% | 0.01% |
| Feb. 14, 2024 | ModivCare Inc | $MODVQ | Norwalk Leslie V | Director | A | Common Stock | 2658 | $0.00 | 18,830.0000 | 19,775,041 | 16.44% | 0.01% |
| Jan. 26, 2024 | GLOBUS MEDICAL INC | $GMED | Norwalk Leslie V | Not found | A | Stock Option (Right to Buy Class A Common Stock) | 15000 | $0.00 | 15,000.0000 | 114,630,000 | 9999.99% | 0.01% |
| June 15, 2023 | ARVINAS, INC. | $ARVN | Norwalk Leslie V | Director | A | Common Stock | 4121 | $0.00 | 4,121.0000 | 53,200,000 | 9999.99% | 0.01% |
| June 15, 2023 | ARVINAS, INC. | $ARVN | Norwalk Leslie V | Director | A | Stock Option (right to buy) | 12787 | $0.00 | 12,787.0000 | 53,200,000 | 9999.99% | 0.02% |
| May 17, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | A | Restricted Stock Unit | 2100 | $0.00 | 2,100.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Norwalk Leslie V | Director | A | Non-Qualified Stock Option | 4290 | $0.00 | 4,290.0000 | 98,900,000 | 9999.99% | 0.00% |
| Feb. 16, 2023 | ModivCare Inc | $MODVQ | Norwalk Leslie V | Director | A | Common Stock | 1314 | $0.00 | 16,172.0000 | 19,729,923 | 8.84% | 0.01% |